Drugs Made In America Acquisition II (DMII) vs Armada Acquisition II (XRPN)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Drugs Made In America Acquisition II is the larger company by market cap ($649.1 million vs $539.9 million), about 1.2 times the size. On valuation, Drugs Made In America Acquisition II trades at a lower trailing P/E (34.0x vs 155.4x for Armada Acquisition II).
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | DMII | XRPN |
|---|---|---|
| Share price | $10.19 | $17.09 |
| Market cap | $649.10M | $539.87M |
| 1-day change | 0.00% | -29.38% |
| P/E ratio (TTM) | 33.97 | 155.36 |
| EPS (TTM) | $0.30 | $0.11 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $10.33 | $53.00 |
| 52-week low | $9.86 | $10.10 |
| Distance from 52-week high | -1.36% | -67.75% |
| Average volume | 57.23K | 551.03K |
| Shares outstanding | 63.70M | 23.71M |
| Sector | Finance | Finance |
| Industry | Blank Checks | Blank Checks |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Armada Acquisition II trades at a higher earnings multiple (155.4x vs 34.0x trailing P/E).
About Drugs Made In America Acquisition II
DMII stock →Drugs Made In America Acquisition II Corp. does not have significant operations.
Finance · Blank Checks
About Armada Acquisition II
XRPN stock →Armada Acquisition Corp. II focuses on effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses in the technological services.
Finance · Blank Checks
DMII vs XRPN FAQ
Which is bigger, Drugs Made In America Acquisition II or Armada Acquisition II?
Drugs Made In America Acquisition II (DMII) is larger, with a market capitalization of $649.10M compared with $539.87M for Armada Acquisition II (XRPN).
Which has the lower P/E ratio, DMII or XRPN?
DMII has the lower trailing P/E at 34.0, versus 155.4 for XRPN. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Are Drugs Made In America Acquisition II and Armada Acquisition II in the same industry?
Yes. Both are classified in the Blank Checks industry within the Finance sector.